Targacept , Inc. (NASDAQ:TRGT)

CAPS Rating: 1 out of 5

A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system.

Featured Broker Partners


Advertisement